The neuropathogenesis of feline immunodeficiency virus infection: barriers to overcome.
Feline immunodeficiency virus (FIV), like human immunodeficiency virus (HIV)-1, is a neurotropic lentivirus, and both natural and experimental infections are associated with neuropathology. FIV enters the brain early following experimental infection, most likely via the blood-brain and blood-cerebrospinal fluid barriers. The exact mechanism of entry, and the factors that influence this entry, are not fully understood. As FIV is a recognised model of HIV-1 infection, understanding such mechanisms is important, particularly as HIV enters the brain early in infection. Furthermore, the development of strategies to combat this central nervous system (CNS) infection requires an understanding of the interactions between the virus and the CNS. In this review the results of both in vitro and in vivo FIV studies are assessed in an attempt to elucidate the mechanisms of viral entry into the brain.
Fletcher
Nicola F
NF
Veterinary Sciences Centre, School of Agriculture, Food Science and Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland.
Meeker
Rick B
RB
Hudson
Lola C
LC
Callanan
John J
JJ
D000818:Animals; D001812:Blood-Brain Barrier; D001921:Brain / Q000821:virology*; D002415:Cats; D004195:Disease Models, Animal; D016181:Feline Acquired Immunodeficiency Syndrome / Q000821:virology*; D015658:HIV Infections; D015497:HIV-1; D006801:Humans; D016089:Immunodeficiency Virus, Feline / Q000472:pathogenicity*